Barchart.com Type 1 Diabetes Market Report 2032: Latest FDA, EMA, PDMA, Pipeline Therapies, EpidemiologyDelveInsight's “Type 1 Diabetes Market Insights, Epidemiology, Market Forecast – 2032” report provides a detailed understanding of …
Tag:
therapies
-
Type 1
-
Type 2
Advances and challenges of the cell-based therapies among diabetic patients | Journal of Translational Medicine
Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, Abbasifard M, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis …
-
General Health
Interview with Stefany Shaheen: Revolutionizing diabetes care through cell therapies
by News Sourceby News Source[00:00:00] Scott K. Johnson: I’m excited to introduce Stefany Shaheen, Chief Strategy Officer of Advanced Regenerative Manufacturing Institute, or ARMI. And BioFab USA, a program of ARMI. Stefany’s background is …